课题基金 / 基金详情

Structure/Function Relationships in HIV-1 Co-Receptors

Structure/Function Relationships in HIV-1 Co-Receptors
HIV-1 辅助受体的结构/功能关系
批准号:
6752008
负责人:
TATJANA DRAGIC
金额:
$37.58万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-06-15 至 2006-05-31

项目摘要

项目成果

TATJANA DRAGIC的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Provided by the applicant): This application is for the competitive renewal of ROl A143847 entitled "Structure/function relationships in HIV-1 co-receptors." Gp120 binding to the CD4 receptor drives reordering of the gpl2O core structure and creates/exposes a co-receptor binding site on gpl2O. CCR5 and CXCR4 are the most biologically relevant HIV-1 co-receptors. Over the past two and a half years, grant A143847 has supported a number of studies that enabled my laboratory to map the determinants of CCR5 and CXCR4 co-receptor function. We demonstrated that negatively charged residues and sulfotyrosines in the CCR5 amino-terminal domain (Nt) interact directly with gpl2O and are indispensable for HIV-1 fusion and entry. We also demonstrated that CXCR4 co-receptor function depends on similar residues in the Nt and second extracellular loop. Our studies with inhibitors of CCR5 co-receptor function showed that regions not directly involved in gpl20 binding also play an important role in viral entry. These findings successfully address the original specific aims and lay the groundwork for advanced studies of co-receptor structure/function relationships. Our continuing goal is to define how HIV-1 envelope glycoproteins interact with fusion co-receptors. To this end, we will elucidate the role of sulfotyrosines in CCR5- and CXCR4-mediated fusion and entry, study co-receptor interactions with envelope glycoproteins from non-clade B isolates, and characterize novel lead compounds that inhibit viral entry by interfering with CCR5 or CXCR4 co-receptor function. Our work will provide a detailed molecular picture of the protein complex that mediates HIV-1 membrane fusion and viral entry, and will advance the development of more potent and specific inhibitors that are clinically relevant.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Eliciting neutralizing antibodies against the HCV E2 envelope glycoprotein
Eliciting neutralizing antibodies against the HCV E2 envelope glycoprotein
Mechanism of HCV Internalization into Target Cells
Mechanism of HCV Internalization into Target Cells